Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)
CNY 252.97
(0.34%)
CNY 252.97
(0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 34.56 Billion | 30.36 Billion | 25.26 Billion | 21.02 Billion | 16.55 Billion | 13.75 Billion |
| Cost of Revenue | 12.56 Billion | 10.88 Billion | 8.84 Billion | 7.36 Billion | 5.75 Billion | 4.59 Billion |
| Gross Profit | 21.99 Billion | 19.48 Billion | 16.42 Billion | 13.65 Billion | 10.8 Billion | 9.15 Billion |
| Operating Expenses | 9.78 Billion | 8.81 Billion | 7.33 Billion | 6.11 Billion | 5.66 Billion | 4.97 Billion |
| Selling, General and Administrative Expenses | 7.47 Billion | 5.16 Billion | 4.33 Billion | 3.89 Billion | 3.83 Billion | 3.41 Billion |
| Research and Development Expenses | 3.43 Billion | 2.92 Billion | 2.52 Billion | 1.86 Billion | 1.46 Billion | 1.26 Billion |
| Other Expenses | -1.11 Billion | 726.57 Million | 472.97 Million | 354.46 Million | 363.21 Million | 99.13 Million |
| Cost and Expenses | 21.86 Billion | 19.69 Billion | 16.17 Billion | 13.48 Billion | 11.41 Billion | 9.57 Billion |
| Operating Income | 13.06 Billion | 10.99 Billion | 9.06 Billion | 7.45 Billion | 5.37 Billion | 4.27 Billion |
| Interest Expense | 85.89 Million | 10.68 Million | 8.63 Million | 70.87 Million | 79.79 Million | 42.5 Million |
| Income Tax Expense | 1.43 Billion | 1.34 Billion | 1.01 Billion | 778.83 Million | 683.43 Million | 512.58 Million |
| Earnings before Tax | 13.01 Billion | 10.95 Billion | 9.01 Billion | 7.43 Billion | 5.36 Billion | 4.23 Billion |
| Net Income | 11.58 Billion | 9.6 Billion | 8 Billion | 6.65 Billion | 4.68 Billion | 3.71 Billion |
| Earnings Per Share Basic | 9.56 | 7.94 | 6.59 | 5.48 | 3.85 | 3.34 |
| Earnings Per Share Diluted | 9.56 | 7.94 | 6.59 | 5.48 | 3.85 | 3.34 |
| Weighted Average Shares Outstanding | 1.21 Billion | 1.2 Billion | 1.21 Billion | 1.21 Billion | 1.21 Billion | 1.11 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.21 Billion | 1.21 Billion | 1.21 Billion | 1.21 Billion | 1.21 Billion | 1.11 Billion |
| Gross Margin | 0.64 | 0.64 | 0.65 | 0.65 | 0.65 | 0.67 |
| EBIT Margin | 0.41 | 0.39 | 0.39 | 0.39 | 0.36 | 0.34 |
| Profit Margin | 0.34 | 0.32 | 0.32 | 0.32 | 0.28 | 0.27 |
| EBITDA | 14.14 Billion | 11.94 Billion | 9.82 Billion | 7.99 Billion | 5.85 Billion | 4.7 Billion |
| Earnings Before Tax Margin | 0.38 | 0.36 | 0.36 | 0.35 | 0.32 | 0.31 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 8.95 Billion | 11.03 Billion | 9.27 Billion | 34.56 Billion | 7.55 Billion | 8.82 Billion |
| Cost of Revenue | 3.43 Billion | 3.98 Billion | 3.19 Billion | 12.56 Billion | 2.76 Billion | 2.89 Billion |
| Gross Profit | 5.52 Billion | 7.04 Billion | 6.08 Billion | 21.99 Billion | 4.78 Billion | 5.93 Billion |
| Operating Expenses | 1.78 Billion | 2.49 Billion | 3.01 Billion | 9.73 Billion | 3.44 Billion | 2.07 Billion |
| Selling, General and Administrative Expenses | 3.83 Billion | 1.73 Billion | 2.02 Billion | - | 2.19 Billion | 2.09 Billion |
| Research and Development Expenses | 817.04 Million | 711.79 Million | 947.43 Million | - | 835.34 Million | 657.49 Million |
| Other Expenses | -2.86 Billion | -47.69 Million | -43.44 Million | 420.28 Million | -409.45 Million | -26.7 Million |
| Cost and Expenses | 5.21 Billion | 6.48 Billion | 6.2 Billion | 22.3 Billion | 6.2 Billion | 4.97 Billion |
| Operating Income | 3.51 Billion | 4.55 Billion | 3.06 Billion | 12.26 Billion | 1.34 Billion | 3.87 Billion |
| Interest Expense | 13.94 Million | 4.66 Million | 4.46 Million | 167.83 Thousand | -8.65 Million | 3.27 Million |
| Income Tax Expense | 382.32 Million | 569.68 Million | 395.92 Million | 1.43 Billion | 81.05 Million | 484.87 Million |
| Earnings before Tax | 3.5 Billion | 4.99 Billion | 3.56 Billion | 13.02 Billion | 1.82 Billion | 3.87 Billion |
| Net Income | 3.07 Billion | 4.4 Billion | 3.15 Billion | 11.58 Billion | 1.74 Billion | 3.39 Billion |
| Earnings Per Share Basic | 2.54 | 3.64 | 2.61 | - | 1.44 | 2.80 |
| Earnings Per Share Diluted | 2.53 | 3.64 | 2.61 | - | 1.44 | 2.80 |
| Weighted Average Shares Outstanding | 1.21 Billion | 1.21 Billion | 1.2 Billion | 1.2 Billion | 1.2 Billion | 1.21 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.21 Billion | 1.21 Billion | 1.21 Billion | 1.21 Billion | 1.21 Billion | 1.21 Billion |
| Gross Margin | 0.62 | 0.64 | 0.66 | 0.64 | 0.63 | 0.67 |
| EBIT Margin | 0.39 | 0.44 | 0.38 | - | 0.21 | 0.44 |
| Profit Margin | 0.34 | 0.40 | 0.34 | 0.34 | 0.23 | 0.38 |
| EBITDA | 3.52 Billion | 4.89 Billion | 3.54 Billion | - | 1.61 Billion | 3.86 Billion |
| Earnings Before Tax Margin | 0.39 | 0.41 | 0.33 | 0.35 | 0.18 | 0.44 |
KREN
1410
OSE
601003
GRVO
BGRIM